20 articles
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.
Czech study reveals how strategic fasting and ketogenic diets can reprogram harmful fat production in obesity.
Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.
Eli Lilly's phase 3 trial pits a novel weekly basal insulin against the gold-standard daily insulin degludec in type 1 diabetes patients.
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Turkish researchers tested whether adding high-fat, low-carb eating to intermittent fasting beats traditional IF for obesity treatment.
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
Columbia University tested whether the diabetes drug metformin could slow memory loss in people with mild cognitive impairment.
Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.
Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.
128-person study compared intermittent fasting approaches to conventional diets for managing diabetes and prediabetes in Pakistani population.
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
New study tests whether meal timing combined with Mediterranean diet can reverse fatty liver disease better than diet alone.
Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.
43 overweight adults followed intermittent fasting with 25% calorie reduction, measuring fat loss, muscle preservation, and metabolic changes.
University of Pennsylvania study tests behavioral tools to help people stick with time-restricted eating for blood pressure and weight management.
VA study tests whether combining lifestyle changes with metformin can reverse muscle loss and frailty in obese older adults.
Small trial tests whether diabetes drug metformin can enhance immune response to flu vaccination in aging adults.
A completed Danish trial investigates how blocking IL-6 signaling with tocilizumab alters fat, glucose, and protein metabolism in humans.
